Company / CIK 0001551152
AbbVie Inc.
ABBV · 8 insiders on file
AbbVie Inc. (ABBV) has 8 insiders on file who disclosed 12 transactions in the last 12 months (0 open-market buys, 1 sale, about $10.8M at reported prices). No federal award to a recipient with exactly this name appears in the last 180 days, and 1 lobbying filing naming it as client report $0 in 2026.
Insiders
| Name | Role | Transactions | Last filed |
|---|---|---|---|
| Donoghoe Nicholas | EVP, CHIEF BUS/STRAT OFFICER | 3 | August 18, 2026 |
| RAPP EDWARD J | Director | 2 | July 2, 2026 |
| Quaggin Susan E | Director | 2 | July 2, 2026 |
| FALK THOMAS J | Director | 1 | May 12, 2026 |
| WADDELL FREDERICK H | Director | 1 | May 12, 2026 |
| Roberts Rebecca B | Director | 1 | May 12, 2026 |
| MEYER MELODY B | Director | 1 | May 12, 2026 |
| Hart Brett J | Director | 1 | May 12, 2026 |
Insider transactions
| Filer | Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Donoghoe Nicholas | ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | — | — | derivative | Form 4 ↗ |
| Donoghoe Nicholas | ABBV | Sell S | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $250 | $8.2M | Form 4 ↗ | |
| Donoghoe Nicholas | ABBV | Option / conversion M | August 14, 2026 | August 18, 2026 | 4d | 32,710 | $79 | $2.6M | Form 4 ↗ | |
| Quaggin Susan E | ABBV | Other A | June 30, 2026 | July 2, 2026 | 2d | 62 | $252 | $16K | derivative | Form 4 ↗ |
| RAPP EDWARD J | ABBV | Other A | June 30, 2026 | July 2, 2026 | 2d | 134 | $252 | $34K | derivative | Form 4 ↗ |
| Hart Brett J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| MEYER MELODY B | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| Quaggin Susan E | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| RAPP EDWARD J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| Roberts Rebecca B | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| WADDELL FREDERICK H | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ | |
| FALK THOMAS J | ABBV | Other A | May 8, 2026 | May 12, 2026 | 4d | 1,118 | — | — | Form 4 ↗ |
Federal contracts (USAspending, last 180 days)
No award action to a recipient named exactly "AbbVie Inc." in the last 180 days. Subsidiaries and differently-spelled recipients are not matched — search contracts.
Lobbying (Senate LDA, as client)
| Period | Registrant | Primary issue | Amount | Source |
|---|---|---|---|---|
| 2026 Q1 | CHECKMATE GOVERNMENT RELATIONS | HCR | — | LDA ↗ |
Sources and method
Insiders and their transactions come from SEC EDGAR Form 4 filings for this issuer. Contracts and lobbying are matched by exact normalized name (suffixes like Inc./Corp. ignored) to USAspending recipients and LDA clients — a conservative match that misses subsidiaries on purpose. See methodology and corrections.
Not investment advice. Public records shown as filed; no recommendation is made or implied.